Back to Stakeholders
Eywa Biotech
Biotech startup focused on biosynthetic psychedelic compounds and clinical-grade supply, with a product slate spanning psilocybin, DMT, 5-MeO-DMT, and bufotenine.
Manufacturing Snapshot
Psychedelic-Focused ManufacturerScope & Capabilities
API ProductionDrug Product Manufacturing
Supply Use Cases
Research UseClinical TrialsCommercial / Licensed Supply
GxP / Compliance
General GxP
Facilities & Access
Eywa positions its platform around biosynthesis of clinical-grade APIs and finished drug products for global research and clinical use.
Manufacturing DetailsSupported Substances
Eywa lists clinical-grade psychedelic compounds and compounds portfolio entries for psilocybin, DMT, 5-MeO-DMT, and bufotenine.
Manufacturing Sources
Quick Facts
- Website
- Visit